These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 32075835)
1. Recovery from recurrent depression with mindfulness-based cognitive therapy and antidepressants: a qualitative study with illustrative case studies. Tickell A; Byng R; Crane C; Gradinger F; Hayes R; Robson J; Cardy J; Weaver A; Morant N; Kuyken W BMJ Open; 2020 Feb; 10(2):e033892. PubMed ID: 32075835 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study). Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157 [TBL] [Abstract][Full Text] [Related]
4. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A Trials; 2010 Oct; 11():99. PubMed ID: 20961444 [TBL] [Abstract][Full Text] [Related]
5. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial. Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A Trials; 2014 Jun; 15():217. PubMed ID: 24916319 [TBL] [Abstract][Full Text] [Related]
6. Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers. Huijbers MJ; Wentink C; Simons E; Spijker J; Speckens A BMJ Open; 2020 Nov; 10(11):e039053. PubMed ID: 33177138 [TBL] [Abstract][Full Text] [Related]
7. Does mindfulness-based cognitive therapy with tapering support reduce risk of relapse/recurrence in major depressive disorder by enhancing positive affect? A secondary analysis of the PREVENT trial. Dunn BD; Warbrick L; Hayes R; Montero-Marin J; Reed N; Dalgleish T; Kuyken W J Consult Clin Psychol; 2024 Sep; 92(9):619-629. PubMed ID: 39418459 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial. Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762 [TBL] [Abstract][Full Text] [Related]
10. Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial. Wentink C; Huijbers MJ; Lucassen P; Kramers C; Akkermans R; Adang E; Spijker J; Speckens AEM BMC Fam Pract; 2019 Jul; 20(1):105. PubMed ID: 31349796 [TBL] [Abstract][Full Text] [Related]
11. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien. Pahlevan T; Ung C; Segal Z Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325 [TBL] [Abstract][Full Text] [Related]
13. Low-Intensity Guided Help Through Mindfulness (LIGHTMIND): study protocol for a randomised controlled trial comparing supported mindfulness-based cognitive therapy self-help to supported cognitive behavioural therapy self-help for adults experiencing depression. Strauss C; Arbon A; Barkham M; Byford S; Crane R; de Visser R; Heslin M; Jones AM; Jones F; Lea L; Parry G; Rosten C; Cavanagh K Trials; 2020 May; 21(1):374. PubMed ID: 32366320 [TBL] [Abstract][Full Text] [Related]
14. 'Mind the gaps': the accessibility and implementation of an effective depression relapse prevention programme in UK NHS services: learning from mindfulness-based cognitive therapy through a mixed-methods study. Rycroft-Malone J; Gradinger F; Owen Griffiths H; Anderson R; Crane RS; Gibson A; Mercer SW; Kuyken W BMJ Open; 2019 Sep; 9(9):e026244. PubMed ID: 31501097 [TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol. Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106 [TBL] [Abstract][Full Text] [Related]
16. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up. Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511 [TBL] [Abstract][Full Text] [Related]
17. Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial. Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Rogier A; Donders T; Speckens AE Br J Psychiatry; 2016 Apr; 208(4):366-73. PubMed ID: 26892847 [TBL] [Abstract][Full Text] [Related]
18. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT. Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078 [TBL] [Abstract][Full Text] [Related]
19. How does mindfulness-based cognitive therapy work? Kuyken W; Watkins E; Holden E; White K; Taylor RS; Byford S; Evans A; Radford S; Teasdale JD; Dalgleish T Behav Res Ther; 2010 Nov; 48(11):1105-12. PubMed ID: 20810101 [TBL] [Abstract][Full Text] [Related]
20. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial. Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]